Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.2765
+0.0072 (2.67%)
Sep 15, 2026, 10:16 AM EDT - Market open
Cosmos Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 73.73 | 65.27 | 54.43 | 53.38 | 50.35 | 56.24 | |
Revenue Growth | 33.82% | 19.93% | 1.97% | 6.02% | -10.48% | 1.50% |
Cost of Revenue | 66.15 | 57.38 | 50.12 | 49.03 | 44.39 | 47.91 |
Gross Profit | 7.57 | 7.9 | 4.31 | 4.35 | 5.96 | 8.33 |
Selling, General & Admin | 23.86 | 22.55 | 17.78 | 25.4 | 13.24 | 12.41 |
Research & Development | 0.5 | 0.52 | 0.53 | 0.16 | - | - |
Operating Expenses | 25.75 | 24.44 | 19.56 | 26.18 | 13.43 | 12.86 |
Operating Income | -18.17 | -16.54 | -15.25 | -21.83 | -7.47 | -4.53 |
Interest Expense | -3.7 | -2.62 | -1.01 | -0.87 | -3.97 | -3.58 |
Interest & Investment Income | 0.29 | 0.4 | 0.41 | 0.66 | 0.24 | 0.05 |
Currency Exchange Gain (Loss) | -0.62 | 0.34 | -0.12 | 0.2 | -0.41 | -0.49 |
Other Non Operating Income (Expenses) | 1.25 | 0.7 | 0.09 | -0.06 | -2.44 | -0.07 |
EBT Excluding Unusual Items | -20.95 | -17.72 | -15.89 | -21.9 | -14.06 | -8.63 |
Gain (Loss) on Sale of Investments | 0.01 | 0.02 | 0 | 0 | 0 | 0 |
Asset Writedown | -0.16 | -0.16 | -0.29 | - | - | - |
Other Unusual Items | -3.28 | -1.28 | - | 3.35 | 1 | 0.78 |
Pretax Income | -24.39 | -19.14 | -16.18 | -18.54 | -13.06 | -7.85 |
Income Tax Expense | - | - | - | - | 0.78 | 0.11 |
Net Income | -24.39 | -19.14 | -16.18 | -18.54 | -13.83 | -7.96 |
Preferred Dividends & Other Adjustments | - | - | 6.2 | 7.24 | 50.11 | 7.63 |
Net Income to Common | -24.39 | -19.14 | -22.38 | -25.78 | -63.95 | -15.59 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 43 | 30 | 19 | 12 | 2 | 1 |
Shares Outstanding (Diluted) | 43 | 30 | 19 | 12 | 2 | 1 |
Shares Change | 78.05% | 58.19% | 59.98% | 520.73% | 193.51% | 23.41% |
EPS (Basic) | -0.56 | -0.63 | -1.17 | -2.15 | -33.16 | -23.74 |
EPS (Diluted) | -0.57 | -0.63 | -1.17 | -2.15 | -33.16 | -23.74 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -9.93 | -8.5 | -8.14 | -18.61 | -14.94 | -7.68 |
Free Cash Flow Per Share | -0.23 | -0.28 | -0.42 | -1.55 | -7.75 | -11.69 |
Gross Margin | 10.27% | 12.10% | 7.92% | 8.15% | 11.83% | 14.81% |
Operating Margin | -24.65% | -25.34% | -28.02% | -40.90% | -14.85% | -8.06% |
Profit Margin | -33.08% | -29.33% | -41.12% | -48.30% | -127.01% | -27.73% |
Free Cash Flow Margin | -13.47% | -13.03% | -14.95% | -34.87% | -29.68% | -13.65% |
EBITDA | -16.79 | -15.18 | -14.03 | -21.24 | -7.37 | -4.18 |
EBITDA Margin | -22.77% | -23.26% | -25.78% | -39.79% | -14.64% | -7.43% |
D&A For EBITDA | 1.38 | 1.36 | 1.22 | 0.59 | 0.1 | 0.35 |
EBIT | -18.17 | -16.54 | -15.25 | -21.83 | -7.47 | -4.53 |
EBIT Margin | -24.65% | -25.34% | -28.02% | -40.90% | -14.85% | -8.06% |